De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region. (2022)
Attributed to:
Exploring novel binding pockets in DNA gyrase and DNA topoisomerase IV to address antibiotic resistance
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d2md00049k
PubMed Identifier: 35919336
Publication URI: http://europepmc.org/abstract/MED/35919336
Type: Journal Article/Review
Volume: 13
Parent Publication: RSC medicinal chemistry
Issue: 7
ISSN: 2632-8682